We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
Cap. Flow
+$7.6B
Cap. Flow %
5.51%
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351

Sector Composition

Rank Sector Weight
1 Healthcare 12.22%
2 Technology 11.9%
3 Financials 9.98%
4 Consumer Discretionary 7.32%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATM
2951
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$1.14M ﹤0.01%
25,423
-5,501
-18% -$209K
OVID icon
2952
Ovid Therapeutics
OVID
$414M
$1.13M ﹤0.01%
+272,164
New +$859K
XRT icon
2953
State Street SPDR S&P Retail ETF
XRT
$449M
$1.13M ﹤0.01%
+24,520
New +$1.08M
ALEX
2954
DELISTED
Alexander & Baldwin
ALEX
$1.13M ﹤0.01%
53,751
-9,755
-15% -$221K
APAM icon
2955
Artisan Partners
APAM
$2.79B
$1.12M ﹤0.01%
34,791
-8,037
-19% -$232K
DIN icon
2956
Dine Brands
DIN
$456M
$1.12M ﹤0.01%
13,450
-1,260
-9% -$97.9K
AROC icon
2957
Archrock
AROC
$6.27B
$1.12M ﹤0.01%
111,828
+9,148
+9% +$85.3K
RCKT icon
2958
Rocket Pharmaceuticals
RCKT
$340M
$1.12M ﹤0.01%
49,289
-22,106
-31% -$369K
CNR
2959
Core Natural Resources Inc
CNR
$4.02B
$1.12M ﹤0.01%
77,273
-47,287
-38% -$653K
DHT icon
2960
DHT Holdings
DHT
$2.99B
$1.12M ﹤0.01%
135,349
+100,522
+289% +$745K
VKTX icon
2961
Viking Therapeutics
VKTX
$3.7B
$1.12M ﹤0.01%
139,696
+100,356
+255% +$732K
FSLR icon
2962
CALL
First Solar
FSLR
$22.7B
$1.12M ﹤0.01%
20,000
FSLR icon
2963
PUT
First Solar
FSLR
$22.7B
$1.12M ﹤0.01%
20,000
TCBK icon
2964
TriCo Bancshares
TCBK
$1.84B
$1.12M ﹤0.01%
27,361
-344
-1% -$13.1K
ICPT
2965
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.11M ﹤0.01%
9,000
-11,000
-55% -$985K
BKE icon
2966
Buckle
BKE
$2.25B
$1.11M ﹤0.01%
41,094
+15,747
+62% +$374K
SMTA
2967
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$1.11M ﹤0.01%
1,447,946
+1,391,192
+2,451% +$3.9M
FLXN
2968
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.11M ﹤0.01%
53,442
-38,689
-42% -$652K
SRI icon
2969
Stoneridge
SRI
$195M
$1.1M ﹤0.01%
37,599
+6,255
+20% +$193K
NPO icon
2970
Enpro
NPO
$6.63B
$1.1M ﹤0.01%
16,457
-3,733
-18% -$248K
SMSI icon
2971
Smith Micro Software
SMSI
$14.5M
$1.1M ﹤0.01%
+6,917
New +$1.37M
SCHL icon
2972
Scholastic
SCHL
$767M
$1.09M ﹤0.01%
28,446
+2,220
+8% +$83.7K
ARVN icon
2973
Arvinas
ARVN
$518M
$1.09M ﹤0.01%
26,601
+13,663
+106% +$400K
GCO icon
2974
Genesco
GCO
$425M
$1.09M ﹤0.01%
22,793
+7,361
+48% +$305K
BFS
2975
Saul Centers
BFS
$836M
$1.09M ﹤0.01%
20,710
-1,376
-6% -$72.7K

Similar funds

Credit Suisse's Q4 2019 Portfolio in Review

As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.

  • Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
  • Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
  • Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
  • Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
  • Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
  • Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.